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Abstract 
NK cell cytolysis of infected or transformed cells can be mediated by engagement of the 
activating immunoreceptor NKG2D with one of eight known ligands (MICA, MICB and 
RAET1E-N) and is essential for innate immunity.  As well as diversity of NKG2D ligands 
having the same function, allelic polymorphism and ethnic diversity has been reported. We 
previously determined HLA class I allele and haplotype frequencies in Kolla South American 
Indians who inhabit the northwest provinces of Argentina, and were found to have a similar 
restricted allelic profile to other South American Indians and novel alleles not seen in other 
tribes.  In our current study, we characterized retinoic acid early transcription-1 (RAET1) 
alleles by sequencing 58 unrelated Kolla people.  Only three of six RAET1 ligands were 
polymorphic.  RAET1E was most polymorphic with five alleles in the Kolla including an 
allele we previously described, RAET1E*009 (allele frequency (AF) 5.2%).  Four alleles of 
RAET1L were also found and RAET1E*002 was most frequent (AF = 78%).  Potential 
functional diversity only affected RAET1E and RAET1L, which were in linkage 
disequilibrium indicating a selective advantage.   The results suggest that limited RAET1 
polymorphism in the Kolla was not detrimental to human survival but still necessary and may 
affect disease susceptibility or severity. 
 Keywords:  RAET1, innate immunity, Natural Killer cells, Kolla American Indian, 
polymorphism. 
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1. Introduction 
 
The Retinoic Acid Early Transcription 1 genes (RAET1) are situated on the long arm of 
chromosome 6 at 6q24.2-25.3, encoding ten gene loci named RAET1E-N, of which six are 
potentially functional glycoproteins [1-5].  These ligands may also be referred to as UL-16 
binding proteins (ULBP) as several RAET1 molecules bind human cytomegalovirus (CMV) 
glycoprotein, UL-16 [6].  RAET1/ULBP molecules are cell bound activating ligands for the 
Natural Killer Group 2 member D (NKG2D) receptor expressed by Natural Killer (NK), 
NKT, + and CD8+ T cells [7].  RAET1/ULBP molecules are MHC class I-related with 
similar function to MHC-encoded molecules MICA and MICB.  All NKG2D ligands are 
markers of stress and become upregulated in infected or transformed cells, inducing cytolysis 
by NK cells through NKG2D [8, 9].  RAET1 molecules are expressed in diverse tissues such 
as skin, testes, bone marrow, heart and lung [1] whereas MICA/B expression is more limited 
and restricted to most epithelial cells and fibroblasts [8].   
 
Expression of different NKG2D ligands in different tissues may relate to specialized 
functions.  In addition, RAET1 genes encode only 1 and 2 domains with a transmembrane  
(TM) and cytoplasmic domain (RAET1E/ULBP4 and RAET1G/ULBP5) or 
glycophosphatidylinositol (GPI) anchors for cell surface expression (RAET1I/ULBP1, 
RAET1H/ULBP2, RAET1N/ULBP3 and RAET1L/ULBP6) whereas all MICA and MICB 
molecules have 3, TM and cytoplasmic domains.  The functional significance for these 
differences is unknown.  Moreover, allelic polymorphism exists within all the genes encoding 
NKG2D ligands and may indicate that functional variants have arisen, particularly as 
differences in MICA/B and RAET1/ULBP allelic frequencies are observed between ethnic 
groups [5, 10-12].  As with human leukocyte antigen (HLA) polymorphism in adaptive 
immunity, NKG2D ligand polymorphism may confer innate immune resistance to pathogens 
endemic in different regions of the world.  Alleles of NKG2D ligands encoding molecules 
that are perhaps not as efficient for clearing an infection may require an adaptive immune 
response and if this is also impaired through restricted HLA polymorphism, selective 
pressure could occur.  However, whilst allelic polymorphism of MICA and MICB loci has 
been well characterized, little is known of allelic diversity that exists among the 
RAET1/ULBP family of genes and a formal allelic nomenclature system has yet to be 
established.   
 Archaeology and studies of genetic diversity suggest that human habitation of the Americas 
first occurred around 13,000 years ago, towards the end of the last ice age.  It is believed that 
small groups entered North America from Siberia across the Bering Strait and migrated 
southwards, taking 1000 years to reach the southernmost tip of South America [13-15].  We 
refer to descendents of these people as American Indians and they have restricted genetic 
diversity, likely due to a genetic bottleneck created by small founder populations and reduced 
further by disease outbreak during their migration as they encountered new pathogens in 
unfamiliar habitats.  American Indians have been extensively studied for polymorphism of 
HLA loci as they have evolved in relative isolation compared with most populations 
worldwide.  A common genetic feature of American Indians is their restricted HLA 
polymorphism and high frequency of novel alleles not seen in other populations, particularly 
HLA-B, which offers an insight into the selective pressures giving rise to HLA diversity and 
function [13, 16].  Thus, by studying the polymorphism of other genes with immune function, 
such as RAET1/ULBP, in American Indians it may be possible to avoid some of the 
complexity derived from population admixture and reveal polymorphisms that may be 
essential for innate resistance to pathogens. 
 
We have previously studied HLA class I allele and haplotype diversity in Kolla South 
American Indians [17].  The Kolla (or Colla, Qulla) are an indigenous people of Western 
Bolivia, Chile, and Argentina and currently situated in Jujuy and Salta Provinces of northwest 
Argentina. They moved freely between the borders of Argentina and Bolivia and admixture 
between Argentinean and Bolivian Kolla is known.  Their lands are part of the yungas, or 
high altitude forests, at the edge of the Amazon rainforest.  The 2004 Complementary 
Indigenous Survey reported 53,019 Kolla households living in Argentina [18].  Our previous 
studies found that HLA-A, -B and –C alleles characteristic of other South American Indian 
tribes also predominate in the Kolla and one novel allele was present for each of the class I 
loci [19, 20].  Generation of novel alleles by point mutation of common founder alleles is a 
feature of American Indian HLA polymorphism and these new variants often increase in 
frequency to become predominant.  Although this has not occurred yet in the Kolla, all the 
novel variants appeared to be derived from putative founder alleles.  The data suggests that 
diversification of HLA alleles occurred after separation of the founding population into 
localized tribes, supporting the hypothesis that diversity is driven by selective pressure on 
new alleles that may enable a more efficient adaptive immune response against local 
pathogens.  In innate immunity, ligands for the NK cell activatory receptor, NKG2D, also 
have varying levels of polymorphism encoded by MICA, MICB and RAET1E-N genes.  It is 
unknown why there are numerous ligands for NKG2D or why they display such 
polymorphism, but it is probable that innate resistance to pathogens is maintained by 
variability in NKG2D ligands. Thus, the current study is an analysis of allelic polymorphism 
and haplotypes of RAET1 gene loci in the same cohort of Kolla South American Indians, to 
further understanding of the relevance of NKG2D ligand diversity and polymorphism in 
innate NK cell immunity. 
 
2. Materials and methods 
 
2.1 Sample collection 
 
Peripheral blood lymphocytes were collected from 70 unrelated Kolla individuals who were 
mother and father of the family where possible.  Efforts were made to ensure siblings of those 
already sampled were excluded.  DNA was extracted using in-house salting-out protocols.  
These DNA samples had been used in previous studies [17, 19-21] and for this study, 58 of 
the original 70 DNA samples could be utilized. 
 
2.2 Sequence-Based typing of RAET1 genes 
 
Direct sequencing of polymorphic loci RAET1E, G, H, I, L and N (ULBP4, 5, 2, 1, 6, 3 
respectively) was performed by amplification of exons 2-3 and bi-directional sequencing of 
the exons where necessary, as previously described [2, 11] and recently updated [11].  A 
summary of amplification and sequencing primers used in this study are provided in 
supplementary Table S1.  The Heterozygous combinations of alleles were resolved using 
MATCHTOOLS 1.0 (Applied Biosystems, CA, USA) with RAET1 allele libraries.  An 
additional cohort of 42 European-Caucasoid cell-line DNA samples were identified from 
DNA available in our laboratory using the IMGT/HLA database 
(http://www.ebi.ac.uk/ipd/imgt/hla/) [22] and typed for RAET1E/ULBP4 polymorphism.  
Details of cell-line DNA and RAET1E/ULBP4 typing results are given in Table S1.  
 
2.3 Frequency analysis 
 
Allele frequencies and haplotypes were analyzed using Arlequin 3.5 [23].  RAET1 two-locus 
haplotype frequencies and linkage disequilibrium (LD) were determined by ELB (Bayesian) 
algorithm for best gametic phases to obtain D’ and R2.  Three-locus haplotypes were 
generated using Maximum Likelihood Estimation (MLE).  Hardy-Weinberg equilibrium 
(HWE) was assessed by exact test using Markov chain Monte Carlo method. 
 
3. Results 
 
3.1 RAET1 nomenclature and allelic polymorphism 
 
The genomic organization of expressed RAET1 genes is provided in Figure 1.  In this study, 
four of the six expressed RAET1 genes were found to be polymorphic.  Nucleotide 
polymorphism giving rise to alleles within RAET1E, G, H and L gene loci (ULBP4, 5, 2, 6 
respectively) are shown by alignment of polymorphic positions in Table 2.  All allele 
sequences are available from DNA sequence repositories and their associated accession 
numbers are shown.  New alleles were determined by BLASTn searches of potentially novel 
sequences.  The nomenclature is based on the naming system proposed by Romphruk and 
colleagues [11] and new alleles were named numerically in order of their discovery after 
cloning and sequencing in isolation where necessary, as previously reported [24].   
 
Polymorphism within exons 2-3 of RAET1 loci in Kolla individuals was observed for 
RAET1E, H and L.  No variation was seen for RAET1I as polymorphism of this locus is rare 
[11, 12] and similarly, we did not detect any variation of RAET1G or RAET1N 
(polymorphism is in exon 1) in Kolla samples.  Currently, the most polymorphic locus is 
RAET1E with ten alleles including three alleles, RAET1E*008, 009 and 010, we described 
recently [24].  RAET1E*008 was sequenced from homozygous Italian-Caucasoid cell line 
CALEGERO (IHW09084).  RAET1E*009 was unique among Kolla individuals and 
RAET1E*010 was detected among 8.3% of European-Caucasoid cell line DNA samples 
(n=42) listed in Table 1.  All three alleles had ‘A’ at nucleotide position 383, only previously 
seen in the RAET1E*002 allele, with other nucleotides arising from point mutation or 
recombination with other RAET1E alleles. The next most polymorphic locus was RAET1L 
with seven alleles, followed by RAET1H with six alleles and RAET1G with three alleles.  
 
3.2 RAET1 allele frequencies 
 
Allele frequencies in Kolla samples are shown in Table 3.  For RAET1E, the most frequent 
allele was RAET1E*002 with a frequency of 0.56035 followed by RAET1E*005 (0.3707) 
and RAET1E*009 (0.0517).  Two other alleles were also detected with low frequency: 
RATE1E*001 (0.0086) and RAET1E*004 (0.0086).  This compares with six alleles detected 
among 42 Euro-Caucasoid cell line DNA samples with frequencies above 1%:  
RAET1E*001 (0.143), 002 (0.238), 003 (0.369), 005 (0.143), 008 (0.024) and 010 (0.083).  
RAET1G*001 was the only allele within this locus detected in Kolla samples and there was 
also no variation of exons 2-3 of RAET1N.  RAET1H*002 was most prevalent, having a 
frequency of 0.862 with the remainder carrying the RAET1H*001 allele (0.138).  Analysis of 
RAET1L revealed four alleles among the Kolla.  RAET1L*002 was most frequent (0.776) 
followed by 001 (0.138), 003 (0.078) and 004 (0.0086).  All polymorphic loci found in the 
Kolla had an allele distribution that was in agreement with HWE principle (supplementary 
Table S2). 
 
3.3 Two-locus RAET1 haplotypes and linkage disequilibrium 
 
Two-locus RAET1 haplotypes having significant LD are given in Table 4.  The two loci in 
strongest LD were RAET1E and RAET1H and the alleles of these loci having highest 
frequency and positive LD were RAET1E*002 – RAET1H*002 with a frequency, D’, R2, 
and P-value of 0.5431, 0.77692, 0.12309 and 0.0002 respectively.  The next most prevalent 
haplotype for this pair of loci was RAET1E*005 – RAET1H*002 found among 25% of the 
Kolla (D’=-0.80137, R2 = 0.17444, P<0.0001) but these alleles had a negative LD, indicating 
a tendency to not occur together.  Moderate LD at high frequency was found between 
RAET1E and RAET1L.  RAET1E*002 – RAET1L*002 had the highest frequency of 
0.38793 but had a negative LD (D’, R2, and P-value of -0.47511, 0.05117, 0.0148, 
respectively).  The next most frequent was RAET1E*005 – RAET1L*002 and had moderate, 
positive LD (frequency = 0.33621, D’=0.58497, R2 = 0.05823, P=0.0094).  RAET1E*002 
was also found in positive LD with RAET1L*001 (frequency = 0.11207, D’=0.57353, R2 = 
0.04129, P=0.0286).  Low to moderate positive LD also existed between RAET1H*001 and 
RAET1L*001 at relatively low frequency (frequency = 0.04310, D’=0.58497, R2 = 0.05823, 
P=0.0094). 
 
3.4 Three-locus RAET1E, RAET1H and RAET1L haplotypes 
 
Common three-locus RAET1 haplotypes are listed in Table 5.  Two haplotypes were found 
with a combined frequency of 0.6379, both having RAET1H*002 and RAET1L*002 but 
differing by RAET1E*002 or 005 (38.8% and 25% respectively).  Interestingly, although the 
strongest associations were generally between RAET1E and RAET1H (Table 4), these 
highest frequency haplotypes differed in their associations.  RAET1E*002 was more 
associated RAET1H*002 and RAET1E*005 was associated with RAET1L*002. Six other 
haplotypes were also present among 1-10% of the Kolla people.  Notably, the Kolla allele 
RAET1E*009 was only found in combination with RAET1H*002 and RAET1L*002, with a 
haplotype frequency that was the same as the allele frequency (0.05172). 
 
3.5 Comparison of RAET1E and RAET1L frequencies in the Kolla with other populations 
 
Figure 2a compares RAET1E allele frequencies between Euro-Caucasoid cell-line DNA 
(n=42), Kolla American Indians (n=58) and northeast Thai (NET; n=176) [11].  Clear 
differences are seen between the populations, for example RAET1E*001 has a very high 
frequency of 52.8% in NET but is virtually absent in the Kolla.  RAET1E*003 has highest 
prevalence in Euro-Caucasoid cell-lines (0.369) but was undetected in the Kolla and at a 
much lower frequency in NET (0.074).  The allele with highest frequency in all three groups 
was RAET1E*002. 
 
Figure 2b compares RAET1L allele frequencies in Caucasoid (n=32) [5], Kolla (n=58) and 
NET (n=176).  RAET1L*002 was most prevalent in the Kolla (0.776) and was also frequent 
in Caucasoid (0.420) and NET (0.253).  The most prevalent allele in Caucasoid individuals 
was RAET1L*003 (0.480) and was second most frequent among NET (0.267) but was much 
lower in the Kolla people (0.078). 
 
4. Discussion 
 
The present study demonstrated that RAET1 allele polymorphism was restricted in the Kolla 
compared to other populations.  Three RAET1E/ULBP4 alleles with a combined frequency 
of 98.6% were detected compared with six alleles detected in the majority of European-
Caucasoid cell lines or five alleles in NET individuals [11].  Two other alleles, RAET1E*001 
and *004 were found with frequencies <1% and were likely to have been introduced by gene 
flow.  One of the three frequent alleles detected in the Kolla was the recently described 
RAET1E*009 [24] and to our knowledge, has not been detected in any other population.  
This allele was almost identical to RAET1E*002, the most frequent RAET1E allele (56%), 
and appears to have been generated by a novel non-synonymous point mutation.  The 
haplotype data shows that RAET1E*009 shares the same haplotype as RAET1E*002 and it 
would seem probable that it has derived from the putative founder allele RAET1E*002.  The 
other allele, RAET1E*005, had an allele frequency of 37% in Kolla people and is structurally 
disparate from RAET1E*002 with one residue difference in 1 (exon 2) and three in the 2 
domain (exon 3).  The positions where residues differ among RAET1E alleles are not 
predicted to interact directly with NKG2D but, as noted by others [5, 11, 12], could alter the 
conformation and orientation of residues and allow tighter interaction with NKG2D and 
enhanced NK cell activation.  RAET1E is currently the most polymorphic RAET1 ligand and 
the presence of a novel allele at relatively high frequency in the Kolla may indicate that 
positive selection is generating diversity. 
 
Studies of RAET1/ULBP gene polymorphism and ethnic diversity are rare and limited 
compared to those for MICA/B, but frequencies also differ by ethnicity [2, 5, 11, 12].  The 
study by Romphruk and colleagues of NET RAET1 polymorphism was the first to provide 
frequencies of alleles in polymorphic RAET1 loci in a non-Caucasoid population [11].  The 
results, obtained by direct sequencing, showed differences in frequencies compared with 
Caucasoids and several new allelic variants were also present at low frequency.  Antoun and 
co-workers used single nucleotide polymorphism (SNP) analysis of RAET1 promoter and 
coding regions to study polymorphism of alleles and haplotypes in Euro-Caucasoid, African-
Caribbean and Indo-Asian populations [12].  They also concluded that the distribution of 
SNPs and haplotypes varied considerably within and between different ethnic groups.  It is 
also clear that some loci have low or no polymorphism (RAET1I/ULBP1 and 
RAET1N/ULBP3) whilst other loci, in particular RAET1E/ULBP4 and also 
RAET1L/ULBP6 are very polymorphic, although the functional significance of this is not 
clear.  Modern urban populations are the product of extensive genetic admixture with 
neighboring populations and more recent migration has resulted in further admixture.  As a 
consequence, the ethnic diversity revealed from genetic studies does not accurately reflect 
polymorphisms that have arisen and been maintained by positive selection.  In this respect, 
genetic studies of American Indian populations have proven illuminating due to their relative 
isolation from other ethnic groups.   
 
There are a total of eight known ligands for NKG2D, including MICA/B and the six 
RAET1/ULBP molecules, and individual ligands are also polymorphic.  Differences in 
affinity for NKG2D have been observed between the different ligands, which affect NK cell 
activation, the weakest affinity was with RAET1G [5]. The relevance of RAET1 
polymorphism is largely unknown, however MICA transcription is upregulated by CMV but 
surface expression is prevented by binding of MICA to CMV glycoprotein UL42, affecting 
all MICA types except MICA*008, which has a truncated TM/cytoplasmic tail [25].  In 
addition, RAET1N (ULBP3) can also be bound by UL142, preventing expression, but 
RAET1H (ULBP2) was found to be unaffected [25].  Similarly RAET1 ligands are 
upregulated by CMV infection, but all RAET1 molecules except RAET1N (ULBP3) and 
RAET1E (ULBP4) bind CMV glycoprotein UL16 and are retained within the cytoplasm [1, 
6].  UL16 also binds and prevents expression of MICB, but not MICA [3].  Thus, ligand and 
allelic diversity may have arisen from selective pressure by pathogens driving evolution of 
structural variants that can inhibit such mechanisms.   
 
The small sample size of 58 Kolla individuals is a limitation of this study, which could not be 
avoided and may affect haplotype estimation, although low polymorphism of RAET1 alleles 
may have helped to limit this problem.  Negative LD values observed in this study may also 
be a consequence of the nature of American Indian genetic diversity such as founder effects, 
extensive differentiation of American Indian populations, genetic bottlenecks and gene flow.  
In addition, genetic drift, which is often negligible in large populations, may be exaggerated 
in small or isolated tribes such as the Kolla.  The highest R2 values, in this study, were 
observed between RAET1E and 1H and are in agreement with Rareongjai and colleagues in 
Thai subjects [26].  The two most frequent RAET1E-RAET1H-RAET1L haplotypes in the 
Kolla were 002-002-002 (38.8%) and 005-002-002 (25%) respectively. The polymorphism 
distinguishing RAET1H*001 and 002 at residue 123 is synonymous, therefore potential 
functional diversity (within the 1 and 2 domains) only affects RAET1E and RAET1L and 
these are in positive LD, albeit with low R2 values.  Specifically, RAET1E*005 and 
RAET1L*002 were in positive LD, suggesting a selective advantage in having these two 
common Kolla alleles together. RAET1E*002 and 005 are structurally dissimilar with four 
amino acid differences (residues 82, 128, 141 and 142) at positions predicted to influence 
interaction with NKG2D [12] that may allow differential activation of NK cells.  Similarly, 
RAET1L*001 and *002 differ at residue 85, also predicted to interact with NKG2D.  
Alternatively these polymorphisms may have been selected because they are not recognized 
by pathogens.  As we have only examined the extracellular domains, differences may exist in 
the transmembrane region, which could allow or prevent shedding by metalloproteinases 
possibly leading to NK cell inhibition.  This mechanism of NKG2D ligand shedding has been 
discussed at length as a tumor escape mechanism [27-29] and may also be induced by viral 
infection in order to avoid immune recognition by NK cells.  NKG2D ligands with short 
cytoplasmic tails (such as MICA*008) or with GPI-anchorage (RAET1E and 1G) are 
resistant to degradation within lysosomes as they lack a lysine motif in the cytoplasmic tail, 
enabling them to escape an immune evasion strategy employed by some viruses, such as 
human herpesvirus-7 [30, 31]. Differences may also exist in the promoter regions, known to 
be polymorphic, which could alter the rate of transcription of RAET1 genes.  Future, larger 
studies would benefit from analysis of the entire promoter and coding regions to enable a 
more clear insight into RAET1 function. 
 
In conclusion, investigation of RAET1 alleles and haplotypes in Kolla South American 
Indians revealed limited polymorphism of RAET1E, H and L compared to other populations, 
and no diversity of RAET1I, N and G.  However, LD between some alleles of different loci 
may indicate a selective advantage relating to innate immunity against viruses and/or tumors. 
More studies are required to understand the relevance of polymorphism of MIC and RAET1 
genes in different populations and the implications for innate NK cell immunity.  A better 
understanding of the biological roles may lead to targeted strategies for immunotherapy. 
 
Figure legends 
 
Figure 1: Genomic organization of the RAET1 gene family in humans.  RAET1 genes are 
encoded on the long arm of chromosome 6 (6q24.2-25.3) towards the telomeric end.  Closed 
arrows indicate the relative positions of the six expressed genes.  Shown alongside are the 
relative lengths of the genes and organization of the coding regions shown by closed boxes.  
The leader peptide sequence is indicated by the letter ‘L’, glycophosphatidylinositol 
anchorage sites are indicated by GPI and transmembrane/cytoplasmic regions by TM. 
 
Figure 2: Panel A shows RAET1E allele frequencies in European-Caucasoid cell line DNA, 
Kolla South American Indian and NET populations.  Highest frequencies in Kolla samples 
were RAET1E*002 and *005.  Panel B shows RAET1L allele frequencies in Caucasoid [5], 
Kolla South American Indian and NET populations [11].  Highest frequency RAET1L allele 
in Kolla samples was RAET1L*002.  The frequency distributions for both genes are different 
between the various populations.   
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Table 1.  European-Caucasoid cell line DNA details and RAET1E (ULBP4) genotypes 
Cell Line Namea Aliasa Ethnicity RAET1E* type 
AM IHW09206 Caucasoid - England, Europe 001, 005 
AMI005AN TER202 Caucasoid - Unknown, Europe 003 
APD IHW09291 Caucasoid - Netherlands, Europe 003, 010 
ARBO IHW09102 Caucasoid - Netherlands, Europe 003, 010 
BM21 IHW09043 Caucasoid - Germany/Italy, Europe 002, 003 
BM92 IHW09092 Caucasoid - Italy, Europe 002 
BOB IHW09089 Caucasoid - Germany, Europe 001, 003 
BOLETH IHW09031 Caucasoid - Sweden, Europe 003, 005 
BTB IHW09067 Caucasoid - Scandinavia, Europe 001, 005 
C047 IHW09265 Caucasoid - Spain, Europe 003 
C073 IHW09261 Caucasoid - Spain, Europe 001, 003 
CALOGERO IHW09084 Caucasoid - Italy, Europe 008 
CEK008AN HC12081 Caucasoid - Sweden/Cyprus, Europe 003 
CMD004AN HC10424 Caucasoid - England, Europe 003, 010 
DEM IHW09007 Caucasoid - Germany, Europe 002, 003 
DKB IHW09075 Caucasoid - Netherlands, Europe 002, 003 
DUCAF IHW09019 Caucasoid - France, Europe 003, 010 
EK IHW09054 Caucasoid - Scandinavia, Europe 001, 005 
HERLUF IHW09299 Caucasoid - Denmark, Europe 001, 002 
JHAF IHW09030 Caucasoid - England, Europe 003, 010 
KAS116 IHW09003 Caucasoid - Yugoslavia, Europe 001, 002 
LB IHW09289 Caucasoid - Sweden, Europe 002, 005 
LUY IHW09070 Caucasoid - Netherlands, Europe 002, 005 
MOV002AN EXT-0497 Caucasoid - England, Europe 001, 003 
PGF IHW09318 Caucasoid - England, Europe 003 
PLH IHW09047 Caucasoid - Scandinavia, Europe 002, 005 
QBL IHW09020 Caucasoid - Netherlands, Europe 003 
REN CEK-ND Caucasoid - Wales, Europe 002, 003 
SAVC IHW09034 Caucasoid - France, Europe 001, 003 
SCHU IHW09013 Caucasoid - France, Europe 002 
SPO010 IHW09036 Caucasoid - Italy, Europe 002 
STEINLIN IHW09087 Caucasoid - France, Europe 005, 010 
TL IHW09270 Caucasoid - Unknown, Europe 003, 005 
VAVY IHW09023 Caucasoid - France, Europe 002, 005 
VEN IHW09238 Caucasoid - Unknown, Europe 002 
WIN IHW09095 Caucasoid - Germany, Europe 003, 010 
WT24 IHW09015 Caucasoid - Italy, Europe 003 
WT47 IHW09063 Caucasoid - Italy, Europe 003 
WT49 IHW09285 Caucasoid - Italy, Europe 002, 003 
WT51 IHW09029 Caucasoid - Italy, Europe 001 
WT52 IHW09306 Caucasoid - Italy, Europe 001, 005 
WVB IHW09062 Caucasoid - Netherlands, Europe 002, 005 
a 
Further details of all cell lines utilised can be obtained from the IMGT/HLA database  
(http://www.ebi.ac.uk/ipd/imgt/hla/). 
 
Table 2.  Known RAET1 nucleotide and amino acid polymorphism within exons 2 to 3 of 
alleles revealed by sequence-based typing. 
Allele details Polymorphic nucleotides and amino acids Accession number  
 Exon 2 (89-345) Exon 3 (346-621)  
Nucleotide no.a 134 244 267 296 382 383 421 425  
RAET1E C A A G C G A T  
001 - - - - - - - - JX051312 
002 - - G - - A - - JX051313 
003 - - - - - - G C JX051314 
004 - - - - - - G - JX051315 
005 - T - - - - G C JX051316 
006 - - - - T - - - JX051317 
007 T - - - - - - - JX051318 
008 - - - - - A G - HE804773 
009 - - G A - A - - HE804774 
010 - - - - - A - - HE806193 
Consensus aa Pro Asn Glu Arg Arg Arg Thr Iso  
Variant aa Lys Tyr - Gln Cys His Ala Thr  
Codon no.a 45 82 89 99 128 128 141 142  
 Exon 2 (86-349)      
Nucleotide no.a 209 220       
RAET1G C G       
001 - -      EAW47779, JX162560 
002 G -      JX162561 
003 G A      JX162562 
Consensus aa Thr Val       
Variant aa Arg Ile       
Codon no.a 69 73       
 Exon 2 (86-349) Exon 3 (350-671)   
Nucleotide no.a 114 203 219 369 487    
RAET1H C A T A C    
001 - - - - -   JX162563, JX162569 
002 - - - C -   JX162564, JX162570  
003 - - - C G   JX162565, JX162571 
004 T - - C -   JX162566, JX162572 
005 - - C - -   JX162567, JX162573 
006 - G C C -   JX162568, JX162574 
Consensus aa Thr Asn Pro Ala Pro    
Variant aa - Ser - - Ala    
Codon no.a 38 68 73 123 163    
 Exon 2 (86-349) Exon 3 (350-671)   
Nucleotide no.a 254 317  417 440    
RAET1L T T  T C    
001 - -  - -   JX162575, JX162582 
002 C -  - -   JX162576, JX162583 
003 C G  - T   JX162577, JX162584 
004 C G  - -   JX162578, JX162585 
005 C -  - T   JX162579, JX162586 
006 - -  - T   JX162580, JX162587 
007 C G  C -   JX162581, JX162588 
Consensus aa Met Lys  Arg Thr    
Variant aa Thr Arg  Trp Iso    
Codon no.a 85 77  139 147    
Alternative nomenclature: RAET1E = ULBP4, RAET1G = ULBP5, RAET1H = ULBP2, RAET1L = ULBP6. 
a 
Nucleotide numbering is based on the coding sequence (CDS) of exons 1-3.  Codons/amino acids are 
numbered from exon 1.   
Table 3.   RAET1 allele frequencies among the Kolla 
RAET1E Frequency RAET1G Frequency RAET1H Frequency RAET1N a Frequency RAET1L Frequency 
002 0.56035 001 1.00000 002 0.86207 001/002 1.00000 002 0.77586 
005 0.37069   001 0.13793   001 0.13793 
009 0.05172       003 0.07759 
001 0.00862       004 0.00862 
004 0.00862         
a 
RAET1N allelic polymorphism is located in exon 1 and was not included in the analysis. 
RAET1 allele frequencies were determined by maximum likelihood estimation using Arlequin 3.5 from the phenotypes of 58 unrelated Kolla individuals.  Frequencies above 
1% are shown. 
Abbreviation: RAET1 – retinoic acid early transcript 1. 
Alternative nomenclature: RAET1E = ULBP4, RAET1G = ULBP5, RAET1H = ULBP2, RAET1N = ULBP3, RAET1L = ULBP6. 
Table 4.   Two-locus RAET1 haplotypes exhibiting significant linkage disequilibrium among 
the Kolla 
Haplotype Frequency D’ R2 P value 
RAET1E RAET1H     
002 002 0.54310 0.77692 0.12309 0.0002 
005 002 0.25000 -0.80137 0.17444 <0.0001 
005 001 0.12069 0.80137 0.17444 <0.0001 
RAET1H RAET1L     
002 001 0.09483 -0.20250 0.04101 0.0292 
001 001 0.04310 0.20250 0.04101 0.0292 
RAET1E RAET1L     
002 002 0.38793 -0.47511 0.05117 0.0148 
005 002 0.33621 0.58497 0.05823 0.0094 
002 001 0.11207 0.57353 0.04129 0.0286 
RAET1 two-locus haplotype frequencies were determined by ELB algorithm (Bayesian) using Arlequin 3.5 
from  
the phenotypes of 58 unrelated Kolla individuals.  Frequencies above 1% are shown. 
Abbreviation: RAET1 – retinoic acid early transcript 1. 
Alternative nomenclature: RAET1E = ULBP4, RAET1H = ULBP2, RAET1L = ULBP6. 
Table 5.  RAET1E, RAET1H and RAET1L haplotype frequencies derived from maximum 
likelihood estimation 
RAET1E RAET1H RAET1L Frequency a SD 
002 002 002 0.38793 0.04544 
005 002 002 0.25000 0.04038 
002 002 001 0.09483 0.02732 
005 001 002 0.08621 0.02617 
002 002 003 0.06034 0.02221 
009 002 002 0.05172 0.02065 
005 001 001 0.02586 0.01480 
002 001 001 0.01724 0.01214 
a 
Frequencies greater than 1% are shown. 
Alternative nomenclature: RAET1E = ULBP4, RAET1H = ULBP2, RAET1L = ULBP6. 
Abbreviation: SD – standard  
Table S1: Amplification and sequencing primers for analysis of RAET1 genes  
Amplification Primers 
Locus Primers Location Reference 
RAET1E/ULBP4 5’-TCACCATAAGTGGGAGGAGG-3’ 
5’-CTGAACTCGAGACAGCTTCC-3’ 
Intron 2 F 
Intron 4 R 
[2] 
RAET1G/ULBP5 5’-CTTCCTCTTATTGTCACAGTG-3’ 
5’-CCCCATTTCTGATCTCATTGG-3’ 
Intron 2 F 
Intron 4 R 
[11] 
RAET1H/ULBP2 and 
RAET1L/ULBP6a 
5’-CTTATTGACACACAGCGTGGAG-3’ 
5’-TTGAAGCTGAACTCAAGAAC-3’ 
Intron 2 F 
Intron 4 R 
[2] 
RAET1I/ULBP1 5’-TCACCATAAGTGGGAGGAGG-3’ 
5’-CTGAACTCGAGACAGCTTCC-3’ 
Intron 2 F 
Intron 4 R 
[2] 
RAET1N/ULBP3 5’-CACAGTGTTTGGGGTCTTTC-3’ 
5’-GACAGACAAGGGTGTAACTC-3’ 
Intron 2 F 
Intron 4 R 
[2] 
RAET1H/ULBP2 specificb 5’-TCTTATTGACACAGCGTGGA-3’ 
5’-TTCACCATGTTGGTCAGGCT-3’ 
5’-AATACAAATGGGAAGGTCATCA-3’ 
5’-ATTGAAGCTGAACTCAAGAAC-3’ 
Intron 2 F 
Intron 3 R 
Intron 3 F 
Intron 4 R 
[11] 
RAET1L/ULBP6 specificc 5’-TCTTATTGACACAGCGTGGAG-3’ 
5’-TCACTATGTTGGTCAGGCG-3’ 
5’-AATACAAATGGGAAGGTCATCT-3’ 
5’-ATACAAATGGGAAGGTCATCG-3’ 
5’-ATTGAAGCTGAACTCAAGAAC-3’ 
Intron 2 F 
Intron 3 R 
Intron 3 F 
Intron 3 F 
Intron 4 R 
[11] 
Sequencing primers 
RAET1E/ULBP4 5’-GTCAGGGAGAGATGGGAACA-3’ 
5’-TCTCTTACTGCCTGCCTCTG-3’ 
5’-TGGAGGATGATGGACTTCTC-3’ 
5’-CACAGGGAAGGCTTTTGACC-3’ 
Intron 2 F 
Intron 3 R 
Intron 3 F 
Intron 4 R 
[2] 
RAET1G/ULBP5 5’-CTTCCTCTTATTGTCACAGTG-3’ 
5’-AACCTACCACTGTATCTGCTC-3’ 
5’-AATTGCAAGTGGAAGAGGATG-3’ 
Intron 2 F 
Intron 3 R 
Intron 3 F 
[11] 
RAET1H/ULBP2 5’-TCTTATTGACACAGCGTGGAG-3’ 
5’TTCACCATGTTGGTCAGGCT-3’ 
5’-AATACAAATGGGAAGGTCATCA-3’ 
5’-ATTGAAGCTGAACTCAAGAAC-3’ 
Intron 2 F 
Intron 3 R 
Intron 3 F 
Intron 4 R 
[2] 
[11] 
[11] 
[2] 
RAET1I/ULBP1 5’-GTTACTACTGTGTCTGCTCC-3’ 
5’-CAGCAGAGAGAGCAAGTCC-3’ 
Intron 3 R 
Intron 3 F 
[2] 
[11] 
RAET1L/ULBP6 5’-TCTTATTGACACAGCGTGGAG-3’ 
5’-TCACTATGTTGGTCAGGCG-3’ 
5’-ATACAAATGGGAAGGTCATCK-3’ 
5’-ATTGAAGCTGAACTCAAGAAC-3’ 
Intron 2 F 
Intron 3 R 
Intron 3 F 
Intron 4 R 
[2] 
[11] 
This study 
[2] 
RAET1N/ULBP3 5’-ACACAGAACAGCCCCTGAG-3’ 
5’-CATAGGAGGATGTGGGACAG-3’ 
Intron 3 R 
Intron 3 F 
[2] 
[2] 
a 
These primers co-amplify RAET1H/ULBP2 and RAET1L/ULBP6.  A 1:100 dilution of the purified amplicon 
was prepared as a template for nested PCR using locus specific primers as described by Romphruk et al. [11]. 
b,c 
Locus specific amplification primers generating separate products for exons 2 and 3 to serve as template for 
sequencing primers. 
Abbreviations: F – forward primer; R – reverse primer. 
Table S2.   Hardy Weinberg equilibrium exact test using Markov chain Monte Carlo method 
Locus P value Observed 
heterozygosity 
Expected 
heterozygosity 
SD 
RAET1E 0.92440 0.60345 0.55052 0.00025 
RAET1H 0.27741 0.20690 0.23988 0.00043 
RAET1L 0.21296 0.34483 0.37616 0.00045 
Alternative nomenclature: RAET1E = ULBP4, RAET1H = ULBP2, RAET1L = ULBP6. 
Abbreviation: SD – standard deviation. 
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